Showing results (271-280 of 301) with videos related to

Sort By:
Pageof 31
BMJ Open|November 9, 2022
Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT)Jim Zhong, Sarah Brown, Maria Serra, et al.
Trials|December 21, 2016
Pressure RElieving Support SUrfaces: a Randomised Evaluation 2 (PRESSURE 2): study protocol for a randomised controlled trialSarah Brown, Isabelle L Smith, Julia M Brown, et al.
BMJ Open|November 10, 2025
Personalising anal cancer radiotherapy dose (PLATO): protocol for a multicentre integrated platform trialRussell Frood, Alexandra Gilbert, Duncan Gilbert, et al.
BMJ Open|April 22, 2020
Multiple Interventions for Diabetic Foot Ulcer Treatment Trial (MIDFUT): study protocol for a randomised controlled trialSarah Brown, Jane Nixon, Myka Ransom, et al.
Health Technology Assessment (Winchester, England)|September 28, 2019
Comparing alternating pressure mattresses and high-specification foam mattresses to prevent pressure ulcers in high-risk patients: the PRESSURE 2 RCTJane Nixon, Sarah Brown, Isabelle L Smith, et al.
The Journal of Biological Chemistry|October 13, 2012
Novel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-γVictoria J Hammond, Alwena H Morgan, Sarah Lauder, et al.
European Journal of Medical Genetics|November 15, 2025
An electronic review of clinical outcomes after return of actionable genetic research results from a health system research biobankGiorgio Cocchella, Lillian Phung, Elisabeth Wood, et al.
BMC Musculoskeletal Disorders|December 26, 2014
The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drugNuria C Navarro Coy, Sarah Brown, Ailsa Bosworth, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
The ENGAGE Study: A Randomized Trial Optimizing Uptake of Germline Cancer Genetic Services in Childhood Cancer SurvivorsTara O Henderson, Brian Egleston, Sarah Howe, et al.
Lancet Regional Health. Americas|March 23, 2026
The ENGAGE study: a randomized trial optimizing uptake of germline cancer genetic services in childhood cancer survivorsTara O Henderson, Brian Egleston, Sarah Howe, et al.
Pageof 31